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Phosphorylase kinase (PhK) integrates neural, hormonal, and metabolic signals in skeletal
muscle to tightly regulate glycogen breakdown and energy production. Structurally, PhK is
among the largest and most complex kinases known with a stoichiometry of (αβγδ)4 and a mass
of 1.3x106 Da. The catalytic γ subunit is allosterically controlled through alterations in
quaternary structure initiated by the regulatory α, β and δ subunits. In this study we have chosen
to examine the largest regulatory subunit, α. In addition to participating in intramolecular
interactions within PhK, α is hypothesized to associate extrinsically with skeletal muscle proteins
due to its peripheral location in the holoenzyme. To identify potential muscle protein interactors,
the C-terminus of α , amino acid residues 1060-1237, was screened against a rabbit skeletal
muscle cDNA library via a yeast two-hybrid assay. Interactions were selected by auxotrophic
growth of yeast in the absence of leucine and by expression of β-galactosidase activity. Thirtyseven potential positive clones were initially observed. Secondary selections resulted in 13
putative clones being isolated of which 8 were identified as thyroid hormone receptor interacting
protein 10 (TRIP10). TRIP10, also known as Cdc42 interacting protein 4 (CIP4), is highly
expressed in skeletal muscle and is thought to act as a regulator of the actin cytoskeleton. The
remaining 5 clones were identified as tetratricopeptide repeat protein 1 (TPR1). TPR1 is an
adaptor protein that functions in a wide array of cellular processes and is considered a highly

vii

specific adaptor. The results reported herein are intriguing given that PhK is associated with the
sarcoplasmic reticulum in the A-band / actin filament overlap zone and has previously been
shown to interact with the thin filament protein nebulin. To our knowledge, this is the first report
to identify TRIP10 as a potential sarcomeric protein, and these findings further suggest a role for
PhK in muscle assembly and architecture.

viii

CHAPTER I
INTRODUCTION

Phosphorylase Kinase
Phosphorylase kinase (PhK) was the first protein kinase discovered and belongs to a large
family of well-known serine-threonine kinases. Studies on PhK led to the discovery of covalent
modification of proteins occur via phosphorylation. PhK is among the largest and most complex
enzymes known with a molecular weight of 1.3x106 daltons.

PhK is a hexadecamer made up of

four different subunits α, β, γ and δ. It is involved in the metabolic process of glycogen
breakdown by regulating the activation of glycogen phosphorylase to degrade glycogen to
glucose-1-phosphate (Pickett-Gies and Walsh, 1986).
PhK regulation lies at the interface of hormonal, neural and metabolic extracellular
signals. Hormones that are involved in regulation of carbohydrate metabolism and electrical
signals involved in muscle contraction are examples of the signals that regulate PhK (Heilmeyer,
1991). Other allosteric effectors of PhK include ADP, Mg2+, ATP, Ca2+ /calmodulin, pH, and
proteolysis (Pickett-Gies and Walsh, 1986) (Heilmeyer et al., 1992). Additionally, PhK is
regulated by protein kinase A (PKA), a cAMP dependent kinase, that phosphorylates PhK on the
α and β subunits increasing the specificity of PhK’s phosphotransferase activity response in the
catalytic subunit. The availability of Ca2+ and phosphorylation by PKA cooperatively increase
PhK’s activity, thus making the latter a point of cross-talk for two important signal transduction
pathways (Brushia and Walsh, 1999). Calcium availability stimulates muscle contraction.
Moreover, this signaling also integrates glycogen breakdown for energy availability. By these
means PhK is able to serve at the interface of energy supply and demand (Owen et al., 1995). In
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skeletal muscle PhK can be activated by troponin C, a protein homologous to calmodulin which
exists at high levels in muscle, and such leads to the notion that the former may be the actual
physiological regulator of PhK (Brushia and Walsh, 1999).
PhK is expressed in both liver and skeletal muscle, and the muscle isoform is found in
two different cellular compartments. The majority of the enzyme is located in the cytosol in
association with glycogen phosphorylase and glycogen particles, thus the action of PhK on the
former initiates glycogenolysis to satisfy energy demands for muscle contraction. Moreover, a
smaller portion of PhK in muscle cells is associated with the sarcoplasmic reticulum (SR)
membrane (Heilmeyer et al., 1992) (Thieleczek et al., 1987). Studies of immunological
localization found that the four subunits were located at the sarcolemma and the SR, more
specifically associated with the T tubule at the surface of terminal cisternae (Heilmeyer et al.,
1992) (Georgoussi and Heilmeyer, 1986). The SR is involved in muscle contraction,
specifically, in skeletal muscle it exists in significant amounts and serves as storage for Ca2+.
The release of Ca2+ from the SR is a key activator for the contraction process (Schwartz et al.,
1976) (Van Winkle and Entman, 1979). Therefore, the glycogenolysis process is triggered by
this release of Ca2+ from the SR making the breakdown of glycogen contraction dependent in
muscle that requires the energy produced by further decomposition of glucose-1-phosphate into
useable ATP (Van Winkle and Entman, 1979). Another potential role for PhK at the SR
membrane is to regulate the deactivation by phosphorylation of glycogen synthase, thus it has an
involvement in the regulation of glycogen biosynthesis as well (Polishchuk et al., 1995).
PhK has been purified from a variety of organisms including rabbit, mouse, dogfish, red
bovine skeletal muscle, chicken gizzard, and rat liver (Pickett-Gies and Walsh, 1986). Most
biochemical studies on PhK however have been performed using the rabbit skeletal muscle
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isoform. Due to PhK’s complex nature and large size, it is thought that the holoenzyme may
possess more roles than its physiological function in glycogenolysis activation. The fact that
there is a high amount of PhK in skeletal muscle cells, approximately 1% of soluble protein,
suggests that it may be involved in other physiological functions or cellular processes that have
yet to be discovered (Brushia and Walsh, 1999).
The overall quaternary structure of PhK is a bilobal structure with the appearance of two
parentheses backward to each other joined by a narrow bridge (Trempe et al., 1986). Electron
micrographs have shown that PhK possesses the four α, β, γ and δ subunits arranged in tetramers
that are joined together in D2 symmetry forming two lobes that comprise the holoenzyme (figure
1.1) (Nadeau et al., 2002). Association of two tetramers forms a head-to-head structural
arrangement and one of the tetramers comprises each lobe of the “butterfly”. Other views of
PhK by electron microscopy include the “chalice” and the “tetrad” depending on the orientation
in which the enzyme is displayed (Wilkinson et al., 1994). The β subunit bridges unite the lobes
of the holoenzyme (Brushia and Walsh, 1999). Activation of PhK involves tertiary and
quaternary changes in the α, β and δ subunits leading to an increased catalytic activity of γ. Such
conformational changes in structure associated with PhK’s activation are influenced largely by
the Ca2+ dependent interactions of the γ subunit with α and δ (Rice et al., 2002). PhK can be
activated by autophosphorylation as well and such a process occurs by a conformational change
where two α subunits move to contact each other (Nadeau and Carlson, 1994).
The α subunit is the largest regulatory subunit of PhK with a mass of 138 kDa, and is
composed of 1237 amino acids. The subunit contains a farnesylation site in the cysteine residue
on position 1234, at the very C-terminus, attaching the structure to the SR membrane. One α
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Figure 1.1 PhK structure. The bilobal structure of PhK
showing that its four protomers are identical and are joined by
a β subunit bridge (Nadeau et al., 2002).
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subunit isoform is referred to as alpha-FM because it comes from rabbit fast twitch skeletal
muscle. The alpha-FM contains approximately seven phosphorylation sites. All
phosphorylation sites on the subunit are made up of serine residues and are clustered in a small
section of the protein between amino acid residues 972 to 1030. This region is called the
“multiphosphorylation domain” and constitutes about 5% of the subunit. Serine 1018 within the
domain serves as an important site for phosphorylation by PKA in vivo giving the latter a key
regulatory role with regard to PhK. The α subunit also interacts with calmodulin due to the
existence of domains within the subunit that possess calmodulin binding affinities. The
association between phosphorylation and Ca2+ sensitivity of α gives insight to a regulatory
interplay in the structure (Brushia and Walsh, 1999). A novel interaction of α is that which
occurs with itself within regions outside of the C-terminus involving a leucine zipper domain
found at residues 833 to 854 (Ayers et al., 1999). The α subunit is most sensitive to
chymotrypsin proteolysis, particularly in the activated form of PhK, although phosphorylation of
the enzyme provides protection for the subunit against proteolysis (Trempe and Carlson, 1987).
Another isoform of the α subunit is the α’ subunit which is present in cardiac muscle.
This subunit arises from alternative RNA splicing of the gene in which 58 internal residues are
deleted (Harmann et al., 1991).
The β subunit possesses high homology to the α subunit and together they comprise
approximately 81% of the total mass of PhK. The β subunit has a molecular mass of 125 kDa
and is composed of 1093 amino acid residues (Brushia and Walsh, 1999). Distinctive properties
of the β subunit are yet to be defined, although as mentioned earlier, it serves as a structural
bridge for the holoenzyme conformation (Trempe et al., 1986). β Does indeed work with α in
the regulation of the γ catalytic subunit. In muscle, the β subunit is also farnesylated. Although
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β is highly homologous to α, the two do not share any kind of homology with regard to their
recognizable domains. The N-terminal 32 residues of β is unique however, since it is not found
in the α subunit. Phosphorylation sites exist in the β subunit, but they do not share any similarity
with the sites observed in the α subunit. Both subunits possess distinct calmodulin binding
domains. Thus β is also involved in the activation or deactivation of the catalytic γ subunit
because it contains two calmodulin binding sites (Brushia and Walsh, 1999).
The δ subunit of PhK is an intrinsic molecule of calmodulin and as a result provides Ca2+
dependent regulation to the holoenzyme. The structure of the δ subunit is like the classical
calmodulin molecule, a dumbbell that contains a central alpha helix that connects two Ca2+
pockets. The rabbit skeletal muscle δ has a mass of approximately 16.5 kDa and is composed of
148 amino acid residues. Unlike other calmodulin regulated proteins, in PhK the δ subunit
remains as a part of the holoenzyme even when Ca2+ levels decrease. It has been speculated that
δ interacts with the catalytic γ subunit in a fashion similar to that of troponin C in the troponin
complex. The extended conformation of δ may allow it to have a more expanded range of
contact with the other α and β regulatory subunits in order to accomplish an optimal regulation of
the γ catalytic subunit (Brushia and Walsh, 1999).
Gamma is the catalytic subunit of PhK. The skeletal muscle isoform of γ has an
approximate mass of 45 kDa and is composed of 386 amino acid residues. The catalytic domain
of the subunit is present at the N-terminus from residues 1-298 and the rest of the subunit,
residues 299-386, contains two regulatory calmodulin binding domains. The C-terminus
comprises one-third of the entire subunit, and such a structure has not been observed in other
protein kinases. Activity from the γ subunit is influenced by the presence of the proximal α and
β regulatory subunits by changing its structure (Brushia and Walsh, 1999). Cross-linking
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analyses demonstrate that the regulatory C-terminus of γ makes contacts with both α and δ
subunits within the holoenzyme and that the contact is Ca2+ dependent (Rice et al., 2002).

Glycogen Storage Disease IX: PhK deficiency
PhK deficiency has also been classified as glycogen storage disease IX (GSD type IX)
and accounts for a fourth of all GSD cases, occurring at a frequency of approximately 1 out of
100,000 births (Sanjad et al., 1993) (Burwinkel et al., 1997). The first case of PhK deficiency
was described in 1966 when a female patient had low glycogen phosphorylase activity in the
liver. The deficiency can be classified into four groups depending of the type of tissue affected
(Van Den Berg and Berger, 1990). The most common type of PhK deficiency in man is the Xlinked gene (XLG) deficiency in liver. It is caused by mutations in the PHKA2 gene, which
codes for the αL subunit (Hendrickx et al., 1995). The symptoms associated with the disease are
hepatomegaly, hyperlipidaemia, growth retardation, and delayed motor development. Another
form of the disease, which is less common, is the combination of both liver and muscle PhK
deficiency (Van Den Berg and Berger, 1990). Two types of XLG exist depending on the type of
mutation found in PhK. XLGI mutations lead to low or no α subunit levels, which causes an
overall reduction in total PhK expression. XLGII mutations lead to normal availability of
mutated α producing aberrant PhK activity. In the case of XLGI, it is thought that lack of the α
subunit causes instability of the holoenzyme (Bender and Lalley, 1989).
The second most common type of deficiency is observed in muscle where low PhK
activity has been previously described (Van Den Berg and Berger, 1990). The symptoms from
PhK deficiency in muscle are weakness, cramps and erratic hypotonia (Sanjad et al., 1993). The
severity of symptoms depends on the age of onset; if they are displayed in infancy they are more
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severe. It is possible the that the deficiency in muscle may be caused by a nonsense mutation in
the X- chromosomal α muscle (αM) coding sequence of the PHKA1 gene, and it is more
prominent in males. Thus, it is plausible that a truncated αM subunit causes the premature
degradation of PhK by either of two ways: by obstructing subunit assembly or by enhancing an
unstable quaternary structure (Wehner et al., 1994). The I-strain mouse with spontaneous
glycogenosis is a model animal used for studies on GSD; it has a frameshift mutation in its αM
gene (Schneider et al., 1993).
Another condition that is caused by PhK deficiency is myopathy, which is an autosomal
recessive trait that causes exercise intolerance, muscle weakness and stiffness that usually begins
in childhood or adolescence. Specifically, a mutation is detected in the αM subunit sequence
which occurs at a splice junction and affects an intron, therefore causing an aberrant mRNA. The
mutation may obstruct PhK activity by not allowing the holoenzyme to form tetramers and also
may obstruct splicing efficiency consequently reducing αM mRNA stability (Bruno et al., 1998).

The Yeast Two-Hybrid System
Competition in an industrial race to develop methods with commercial potential in
biological research gave rise to the idea of using yeast transcription factors as tools for revealing
protein-protein interactions. The mechanism developed involves using two distinct hybrid
proteins, where one consists of a DNA binding domain and the other an activation domain each
fused to various proteins of interest. If the two proteins interact then transcription is
reconstituted and used for direct activation of downstream genes (figure 1.2). Typically, reporter
genes used encode nutritional requirements for the yeast or a phenotype gene such as lacZ. The
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irony of this story is that this work was initially denied funding because it appeared to some that
it would not yield any commercial value (Fields and Bartel, 1997).
There are two different systems that were developed, a GAL4 transcription factor based
system and a LexA based system, also known as the “interaction trap.” Initially for the yeast
two-hybrid system to work it was necessary to design components that could be transported
directly to the yeast nucleus following expression of the hybrid proteins in question. An
important breakthrough in development of the system was the use of the GAL4 transcription
factor. GAL4 has the ability to make any protein that is fused to its DNA binding domain
localize directly to the nucleus. This system was tested using β-galactosidase. When fused to
GAL4,
β-galactosidase was successfully directed to the yeast cell nucleus (Silver et al., 1984).
A second component of the system is the LexA protein which functions in gene
repression during DNA damage in E. coli. LexA has the capability to be synthesized in the yeast
cytoplasm and function as a repressor by being directed to the nucleus to deactivate promoter
transcription. In yeast, the LexA protein is able to deactivate GAL1 gene expression by binding
close to the promoter activation area (Brent and Ptashne, 1984). Thus, by using this repressor of
prokaryotic origin, regulation of the yeast gene can be accomplished.
Putting two pieces of the set together, Ptashne and Brent thought of a way of finding a
specific component that could bind GAL4 and still activate transcription. This is the point where
GAL4 and LexA come together. LexA became a good candidate because of its proposed ability
to bind a dimer set, GAL4, to the corresponding operator. When LexA is fused to GAL4, the
former is able to bind at the UASG promoter site and activate transcription of GAL1. Further,

18

AD

bait

1.

BD

prey

2.

AD
prey
bait

BD

LEU2 or lacZ
Reporter genes
3.

AD
prey
bait

BD

LEU2 or lacZ
Reporter genes
Figure 1.2 Schematic of the yeast two-hybrid system. A particular protein
of interest is fused to a transcription factor binding domain, representing the
bait. Separately, a prey, such as a cDNA library is fused to a transcription
factor activation domain (1). If the bait and prey interact (2), they will bring
the two transcription factors into close proximity to activate reporter gene
expression (3). The reporter genes used in this screen were LEU2, which
allows growth of yeast in the absence of leucine and lacZ, which encodes for
β-galactosidase activity.
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LexA is not able to activate the yeast gene by itself. The fact that GAL4 is able to work with
LexA to trigger activation instead of repression of genes, created a viable means of gene
expression (Brent and Ptashne, 1985).
At the same time that the LexA/GAL4 binding pair was devised, other researchers were
also using yeast activators in their studies. Fields and Song, by knowing that GAL4 is a
transcriptional activator with the ability to have two separable domains and can be induced by
the presence of galactose, designed a way to bring the two together by fusing each transcriptional
activation and DNA binding domain to any X and Y protein respectively. Fields and Song
successfully tested their hypothesis by using the known binding partners SNF1 and SNF4 fused
to the GAL4 binding and activation domains, respectively. Association of the two SNF proteins
allows the two transcriptional domains to be brought in enough close proximity to reassemble
GAL4 and activate transcription of GAL1. The above-mentioned combinations were created in
plasmids and then introduced into a yeast strain which lacks GAL4 and the GAL4 repressor
GAL80. In order to detect the interactions, GAL1 was fused to lacZ, thus expression of the latter
would produce β-galactosidase activity. It should be pointed out that these interactions occurred
in media that would allow for detection. That is, the yeast media was galactose based, with Xgal being used as a substrate for β-galactosidase activity (Fields and Song, 1989).
Once successfully tested, the system was said to potentially be capable of being applied
to any set of proteins that interact, whether the interaction is novel or already known. It was
thought that such technology would benefit in finding protein-protein connections and mapping
protein interactions (Fields and Song, 1989).
There are many advantages to using the two-hybrid system to study protein interactions
over conventional biochemical analyses. One such advantage is the fact that associations are
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determined in vivo. Further, the system can also be used to define specific interaction domains on
known interacting proteins. Other advantages of the system include the fact that one protein of
interest called the “bait” can be screened against a cDNA library, or “prey,” to identify new
potential interacting partners. Furthermore, because interactions do occur in eukaryotes all
covalent modifications are present on the proteins which may potentially alter interactions
(Chien et al., 1991).
The two-hybrid assay has many other potential uses as well. Some of these include
potential drug screening methods, identification of protein interaction inhibitors and
determination of protein linkage maps within an organism. An additional advantage of this assay
is that the yeast does not need to be sacrificed, at least not at the screening stage of the assay, and
as opposed to in vitro methods, protein concentrations can be low and the interactions are still
detectable (Fields, 1993).
However, there are some intrinsic flaws that do exist with the yeast two-hybrid system.
Screening of proteins that contain their own domains for transcription activation cannot be
performed, although transcription activators from other eukaryotes do work in yeast. Another
disadvantage of the system is that interactions can only occur in the yeast nucleus, thus
membrane bound proteins could not be considered, but cytoplasmic proteins would be able to be
screened this way, riding “piggyback” on the separable transcription factor domains (Fritz and
Green, 1992). Other types of proteins that cannot be assayed in this system are those involved in
receptor-ligand interactions because their natural environment is on the outside of the cell. Also,
proteins containing an SH2 domain possibly cannot be phosphorylated in the yeast environment
(Fields and Sternglanz, 1994).
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There is the risk of running into false-positive interactions, but such a problem is not the
kind that cannot be remedied. Fields did not stop at creating the two-hybrid system. He moved
forward and with help from other colleagues, found a method to eliminate false-positive
interactions. The lacZ gene, native to E. coli, expression detected by phenotypic change of color
in yeast and the yeast native HIS3 or LEU2 gene expression, induced by lack of histidine or
leucine in selective media, are key selection procedures to eliminate false positives (Bartel et al.,
1993).
Specifically, the two-hybrid system used herein is called the “interaction trap,” which is a
LexA based version of the classical system. In this system, one of the vectors allows for cDNA
expression and the others for a bait and reporter gene. The nutritional markers used in the trap
are also different from the traditional two-hybrid system. The bait vector contains the LexA
DNA binding domain. Selection of this plasmid in yeast is maintained by the presence of the
HIS3gene on the plasmid.

The prey plasmid contains the activation domain to which a cDNA

library is fused. This plasmid is maintained in yeast by selection of the TRP1 gene located on
the vector as well. Positive interactions are selected by auxotrophic growth of yeast using the
low background LexAop fused to the LEU2 gene. In our system there are six operators within
the chromosomal DNA of the EGY48 yeast strain upstream of LEU2. The second reporter gene
is maintained on a plasmid and contains the lacZ gene fused to eight LexA operators. Selection
of this plasmid in yeast is maintained by the URA3 gene. The two lacZ and LEU2 reporter genes
are different in number and type of LexA dependent transcription activation (Fields and Bartel,
1997).
Results from screening via the interaction trap method using LEU2 and lacZ as reporters
of interactions will sometimes reveal that one kind of interacting pair will activate one reporter
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more strongly than the other. Such differences are quite predictable given that one reporter is
chromosomal and the other is plasmid borne. The difference of reporter activity can provide
more information regarding interaction affinity levels however. The transcriptional activity
levels can be measured using a classical β-galactosidase assay and as such can provide an
estimation of the affinity of interaction between the two proteins. Importantly, if the majority of
the proteins isolated from interaction specificity tests are identified as multiple independent
clones, the interactions detected are considered significant (Fields and Bartel, 1997).
Finally, to determine the relative affinity of the protein interactions yeast can be
transformed with the known protein and the newly found interactor. After transformation, βgalactosidase activity can be measured and relative affinity can be estimated by calculation of
Miller units of β-galactosidase activity. Miller units are measures of β-galactosidase activity in
yeast normalized to the original yeast culture concentration at mid-log growth phase. Values can
thus provide information to distinguish between strong, medium and weak interaction affinities
(Gietz et al., 1997), although binding and dissociation constants cannot absolutely be determined.
Other assay systems involve the use of more sensitive substrates for β-galactosidase activity,
such as luminescent or fluorescent substrates.

Research Rationale
The focus of this work was to identify novel interacting partners of PhK in skeletal
muscle. Specifically, our goal was to identify novel binding partners for the regulatory α subunit
of PhK. The hypothesis was that the α subunit likely interacts with other skeletal muscle proteins
due to its peripheral location within the holoenzyme. Based on immunoelectron microscopy, α
runs the length of a protomer lobe to the center of the holoenzyme where it contacts another α
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subunit, thus all four subunits are symmetrically arranged within the PhK structure (Wilkinson et
al., 1994). The very C-terminus of α (a.a.1097-1237) is exposed at the lobe tips where it likely
interacts with other molecules (figure 1.3) (Wilkinson et al., 1994) (Nadeau and Carlson, 1994).
It is likely that the C-terminus of PhKα may be involved in a novel function for the holoenzyme,
one that is not necessarily catalytic (Wilkinson et al., 1994). Previous studies have demonstrated
that a truncated α construct (a.a.1-1059) interacts in a yeast two-hybrid screen with skeletal
muscle proteins nebulin and myosin binding protein-H (Ayers Ph.D. dissertation, 1999). This
construct, however, did not contain the most exposed region of the α subunit. Therefore, the
purpose of this project is to use the very C-terminus of α (a.a. 1060-1237) in a yeast two-hybrid
screen to identify novel interactors of PhKα from muscle.
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Figure 1.3 The C-terminus of PhKα is localized to the
lobe tips of the holoenzyme. Immunoelectron microscopy
by use of a gold labeled antibody detected that the Cterminus of α, amino acid residues 1090-1237, is localized
at the lobe tips (Wilkinson et al., 1994).

CHAPTER II
MATERIALS AND METHODS

Yeast and Bacterial Strains
The yeast strain used for two-hybrid screening and testing was Saccharomyces cerevisiae
strain EGY48 (MATα, his3, trp1, ura3, 6ops-LEU2) (CLONTECH, Palo Alto, CA). Plasmid
manipulations were performed in the Escherichia coli strains XL1-blue and DH5α. Library
containing plasmids were rescued into E. coli strain KC8 (hsdR, leuB600, trpC9830, pyrF::Tn5,
hisB463, lac∆X74, strA, galU, K).

Rabbit Skeletal Muscle cDNA Library and Two-Hybrid Plasmids
A cDNA library derived from soleus muscle poly(A)+ mRNA, isolated from New
Zealand white rabbit, was cloned into the EcoRI-XhoI multiple cloning site on the two-hybrid
activation domain vector pB42AD (Figure 2.2 ) (Ayers et al., 1999) (Gyuris et al., 1993). To
create a nuclearly expressed and functional α subunit construct (amino acid residues 1060 –
1237), a single amino acid mutation was inserted by site directed mutagenesis at residue 1234
replacing a cysteine for a glycine in a conceived farnesylation motif. This α subunit construct
consists of C-terminal residues 1060-1237 (PhKα 1060-1237) and was cloned into the multiple
cloning site on the two-hybrid binding domain vector, pLexA (Figure 2.1) (Gyuris et al., 1993).
Additionally, the reporter construct used, p8op-LacZ, contains the lacZ gene downstream of
eight LexA operators (Figure 2.3) (Estojak et al., 1995).
Other constructs cloned into the pLexA vector were an α subunit construct consisting of
amino acid residues 1-1059, the full length α subunit, p53, and Drosophila bicoid protein.
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Figure 2.1 pLexA plasmid. A PhKα construct of amino acid residues
1060-1237, representing the C-terminus of the subunit was inserted
into the multiple cloning site (MCS) of the pLexA vector to use in a
yeast two-hybrid screen. LexA contains the DNA binding domain
(DNA-BD) and the yeast ADH1 promoter controls its expression.
HIS3 is the marker used for selection in yeast (Gyuris et al., 1993).
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Figure 2.2 pB42AD plasmid. A cDNA library derived from
rabbit skeletal muscle poly(A)+ mRNA was inserted into the
multiple cloning site (MCS) in the pB42AD vector for screening
against the PhKα 1060-1237 bait. The vector contains a B42
acidic activation domain (AD) where the GAL1 promoter
controls its expression. A hemagglutinin epitope tag (HA) and a
nuclear localization signal are also present within the plasmid.
The marker for selection in yeast is TRP1 (Gyuris et al., 1993).
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Figure 2.3 p8op-LacZ plasmid. LacZ is the gene within the
p8op vector used as a reporter of β-galactosidase activity. In
EGY48 yeast LacZ was used to confirm putative positive
interactions observed from the two-hybrid screening of a
skeletal muscle library against PhKα 1060-1237. LacZ is
under the control of eight LexA operators and a minimal
TATA region from the GAL1 promoter (Estojak et al., 1995).
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PhKα 1060-1237, cDNA library and LacZ reporter plasmids were kindly provided by Dr. Gerald
Carlson of the University of Kansas Medical Center, Kansas City, Kansas.

Yeast Transformation
EGY48 yeast cells containing the p8op-LacZ reporter plasmid were made competent for
DNA transformation by growing an overnight starter culture in standard (SD) glucose media
lacking uracil (CLONTECH, Palo Alto, CA) at 30 ˚C, followed by subculture into 300 mL of the
same media to an optical density at 600 nm of 0.3-0.5. Yeast cells were resuspended in 1.5 mL
of 0.1 M lithium acetate (LiAc) and 1X Tris-EDTA (TE) (Fields and Bartel, 1997).
Transformation was performed by combining 5 µg bait DNA (PhKα 1060-1237) and 5 µg
of prey DNA (cDNA library) with 0.1 mg/mL herring sperm testes DNA, competent yeast cells
and 600 µL 40% polyethylene glycol (PEG) solution (1X TE, 0.1 M LiAc, 50% PEG). The
transformation mix was incubated while shaking at 250 rpm at 30 ˚C and then heat-shocked at 42
˚C in a water bath for 15 minutes. Transformed cells were resuspended in 100 µL of 1X TE and
plated onto SD glucose media agar plates lacking histidine, tryptophan, and uracil (-His/-Trp/Ura) with subsequent incubation at 30 ˚C for 3 days.

cDNA Library Screen
Yeast containing bait, prey, and reporter gene plasmids were grown in selective media composed
of galactose and raffinose (gal/raff) lacking leucine, histidine, uracil, and tryptophan (-His/-Trp/Ura/-Leu) (CLONTECH, Palo Alto, CA). The culture was incubated at 30 ˚C shaking for 2.5
hours until it reached an optical density at 600 nm of 0.5. One hundred µL of culture was
transferred to selective media plates (gal/raff -His/-Trp/-Ura/-Leu) also containing X-Gal as a
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substrate for β-galactosidase activity (Fields and Bartel, 1997). Twenty-five plates were
incubated at 30 ˚C for 3 days.
Selection for putative positive interactions was based on yeast leucine prototrophy and
expression of the reporter gene lacZ. Yeast colonies showing putative positive interactions were
restreaked onto selective media (gal/raff -His/-Trp/-Ura/-Leu) to differentiate true positive
interactions. In order to maintain viable putative positive colonies long term, yeast were streaked
onto SD glucose -His/-Trp/-Ura master plates.

Isolation of Putative Positive Clones
Yeast colonies containing putative positive interactors were lysed for plasmid isolation
per standard protocol (Fields and Bartel, 1997). The E. coli strain KC8 was used for its ability to
grow in media deficient in leucine, tryptophan and histidine, which correspond to the bait, prey
and reporter plasmids. The KC8 bacteria was prepared for electroporation by growing a culture
of these cells in 250 mL LB media (10g Bacto-tryptone, 5g yeast extract, 10g NaCl, pH 7.0) until
the optical density measured at 600 nm was 0.618. The KC8 culture was made electrocompetent
by concentrating the cells by centrifugation at 4,200 rpm for 20 minutes in a Beckman GSA rotor
and re-suspending the cell pellet in ice-cold de-ionized water followed by the addition of 20 mL
of 10% glycerol.
Electroporation of plasmid DNA from the yeast into electrocompetent KC8 E. coli cells
was performed by use of 2 mm gap electroporation cuvettes (Fisher Scientific, Pittsburgh, PA)
on a BIO-RAD Gene Pulser II set to 2.5 kV, 25 µF and with the pulse controller to 200 Ω. The
bacterial cells were cooled by the addition of LB media and incubated at 37 ˚C for one hour prior
to placing on KC8 selective minimal media agar plates (1g (NH4)2SO4, 4.5g KH2PO4, 10.5g
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K2HPO4, 0.5g sodium citrate·2H2O, and filter sterilized 1 µM thiamine-HCl, 1 µM
MgSO4·7H2O, 0.2% glucose, 5 µg/mL ampicillin, 2 µg/mL histidine, 2 µg/mL leucine, and 2
µg/mL uracil) to select for bacterial cells containing only the library plasmids. Only cells
containing the trp gene found on the pB42AD plasmid grew in the tryptophan deficient media.
Plates were incubated at 37 ˚C overnight. Library plasmid containing bacterial colonies that
grew in KC8 minimal media were selected and plasmid DNA was isolated by use of a QIAprep
Spin Miniprep kit according to the manufacturer’s protocol (QIAGEN, Valencia, CA).

Insert Size Determination
Putative positive clones were analyzed to determine the cDNA library insert size by
digestion of the library plasmids with the enzymes EcoRI and XhoI (New England BioLabs,
Beverly, MA) (Fields and Bartel, 1997). These restriction enzymes flank the insert at the
multiple cloning site on the pB42AD plasmid vector. The digested plasmid DNA was loaded
onto a 1% agarose, 1X TAE buffer (0.04 M Tris-acetate, 0.1 mM EDTA, pH 8.5) gel. The gel
was electrophoresed at 100 volts for 1 hour and then stained with 0.01 mg/mL ethidium bromide
for 1 hour. To determine the insert sizes the fragments were compared with a 1 Kb molecular
weight marker (New England BioLabs, Beverly, MA). The gel was viewed in a UV
Transilluminator FBTI-614 and gel pictures were taken by use of a Kodak DC40 digital camera.

Amplification of Clones by Polymerase Chain Reaction
Polymerase chain reaction (PCR) was used to amplify the cDNA library insert regions of
all putative positive clones. PCR was performed by use of a mixture of plasmid DNA,
deoxyribonucleoside triphosphate (dNTP), Taq DNA polymerase (Promega, Madison, WI),
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buffer and the following primers: forward 5’CCAGCCTCTTGCTGAGTGGAGATG3’ and
reverse 5’CAAGCCGACAACCTTGATTGGAGAC3’ (QIAGEN Sciences, Germantown, MD)
(CLONTECH, 1996). These specific primers were designed to flank the insert region based
upon the multiple cloning site sequence on the pB42AD plasmid. PCR amplification of the
DNA was carried out in a thermocycler (PTC-100 Thermocycler) under the following
conditions: two minute single cycles at 94 ˚C denaturation, 52 ˚C annealing, and 72 ˚C
elongation temperatures, and 29 cycles of thirty seconds at the same denaturation, annealing and
elongation temperatures previously indicated. Subsequently, the amplified DNA was used to
eliminate any redundant clones that had been isolated.

Elimination of Redundant Clones
To eliminate redundant positive clones, the PCR products were cleaned by use of an
Ultra Clean PCR clean-up DNA purification kit per manufacturer’s protocol (MO BIO, Salana,
CA) and digested with the frequent cutter enzyme AluI (New England BioLabs, Beverly, MA).
Restriction digest reactions and a 100 base pair ladder (New England BioLabs, Beverly, MA)
were loaded onto a 2% agarose TAE buffer gel and electrophoresed at 8.6 V/cm for 1.5 hours.
Elimination of redundant clones was carried out by visually examining a photograph of the
agarose gel and determining which clones had the same digestion patterns.

Specificity Tests
To confirm the specificity of the putative interactors of PhKα, yeast containing the LacZ
reporter gene plasmid p8op-LacZ were re-transformed individually with the putative positive
clones and the original PhKα 1060-1237 bait. Yeast were also transformed with the putative
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positive clones and the Drosophila bicoid protein to serve as a non-specific bait. All
transformants were grown on SD glucose –His/-Trp/-Ura plates at 30˚C for 3 days.
To confirm the specificity of each positive clone with PhKα 1060-1237, each of the
above-mentioned transformants were streaked onto two types of selective media plates: SD
glucose -His/-Trp/-Ura/-Leu and gal/raff -His/-Trp/-Ura/-Leu X-Gal plates. The transformants
were grown at 30 ˚C for 3 days. A chloroform-agarose overlay assay (Duttweiler, 1996) was
performed to analyze β-galactosidase activity. Briefly, each plate was overlayed with 10 mL of
chloroform and incubated at 30 ˚C for 5 minutes, followed by the removal of excess chloroform
and drying of plate in a fume hood. The plates were overlayed by adding 10 mL of X-Gal
agarose (1% agarose, 0.1 M NaHPO4 buffer pH= 7.0, 0.25 mg/mL X-Gal) and incubated at 30 ˚C
until blue color developed. β-galactosidase activity was observed at time zero up to a maximum
of 1 hour.

Sequencing and Identification of Positive Clones
To identify the DNAs that remained positive following all secondary selections, the PCR
products of each clone were prepared for sequencing by using approximately 100 ng of PCR
product combined with Big Dye Terminator Ready Mix v3.1 (Applied Biosystems, Foster City,
CA), 1.6 pM forward primer, and sterile water. Amplification of the PCR amplified DNA was
carried out in a thermocycler (PTC-100 Thermocycler) and using the “ABI-SEQR” program as
follows: 96˚C denaturation, 50˚C annealing, and 60˚C elongation. Cycles were repeated 24
times and each temperature setting was for 30 seconds.
Following amplification, the samples were precipitated twice by use of 75% isopropanol
and the sample pellets were dried in a centrifuge vacuum. Each pellet was dissolved in 20 µL of
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ABI PRISM Template Suppression Reagent (TSR) loading buffer (Applied Biosystems, Foster
City, CA), denatured in the thermocycler by heating to 94˚C for 2 minutes, and quick chilled to
4˚C. The samples were subsequently loaded on the sequencer (ABI PRISM 310 Genetic
Analyzer) and sequencing was performed by the standard protocol.

Quantification of β-galactosidase Activity
Yeast cells containing bait, prey and the reporter plasmid p8op-LacZ were grown in SD
glucose media lacking histidine, tryptophan and uracil (-His/-Trp/-Ura) overnight at 30 ˚C while
shaking at 260 rpm. The following day 1.5 mL of each culture was added to 5 mL of induction
media (SD galactose/raffinose -His/-Trp/-Ura) and incubated for an additional 2.5 hours until
cultures reached an optical density of approximately 0.5 at 600 nm signifying mid-log growth
phase. β−Galactosidase activity was quantified in yeast extracts using a chemiluminescent
reporter gene assay (Galacto-Star System, Tropix, Bedford, MA). Briefly, 1.5 mL of each yeast
culture was centrifuged and resuspended in 1.5 mL of Z-buffer (60 mM Na2HPO4·7H2O, 60 mM
NaH2PO4·H2O, 10 mM KCl, 1 mM MgSO4·7H2O, pH 7.0) with 38 mM β-mercaptoethanol.
Cells were lysed by a double freeze-thaw cycle in liquid nitrogen and a 37˚C water bath.
The yeast lysate was assayed in triplicate as follows: 300 µL Galacton-Star reaction
buffer mix was added to 20 µL of the lysate and incubated at room temperature for 1 hour.
Luminescence was measured by use of a luminometer (TD-20/20 Turner Designs Luminometer)
for 10 seconds and the relative light units were recorded for each sample. Data is given as
modified miller units: the average of the relative light unit measurement normalized by the
original yeast culture concentration at approximately mid-log growth phase.

CHAPTER III
RESULTS

Identification of skeletal muscle protein interactions with the C-terminus of PhKα
A yeast two-hybrid assay was performed to screen for putative positive proteins that
interact with the C-terminus (amino acids 1060-1237) of the α subunit of PhK. A cDNA library
derived from New Zealand white rabbit skeletal muscle was fused to a DNA activation domain
(AD) of the pB42AD plasmid vector and used as prey for the screen. Residues 1060-1237 of
PhKα were fused to a DNA binding domain within the pLexA plasmid vector and used as bait
for the screen.
Because the α subunit contains a CAMQ farnesylation motif, to prevent the molecule
from being directed to the cellular membrane, a mutation was performed by site directed
mutagenesis at cysteine residue 1234, replacing it for a glycine. To screen for interactions, the
bait and prey, along with the lacZ reporter plasmid (p8op-LacZ) were transformed into EGY48
yeast resulting in an initial transformation efficiency of 5.7 x 104 colony forming units per µg of
DNA. These transformants were further amplified to approximately 3 x 107 representative
colonies. Subsequently, yeast were grown in selective media that would induce auxotrophic
growth of colonies in the absence of leucine (i.e. induce expression of the LEU2 reporter gene)
and confirm the identity of putative positive clones by their phenotypic expression of βgalactosidase.
For this screen, initially thirty-seven putative positive yeast colonies were observed to
grow in the absence of leucine and metabolize X-gal, the substrate used for measuring
β-galactosidase activity (figure 3.1). Each colony was numbered chronologically in order of
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Figure 3.1 Putative positive interactors of PhKα 1060-1237.
Skeletal muscle cDNA library screening revealed 37 yeast colonies
were observed to contain putative positive interactors of the PhKα
1060-1237 bait. Putative positives were determined by the ability
of yeast to grow in media inducible for LEU2 prototrophy and
express β-galactosidase activity. A total of 20 clones were
successfully rescued in KC8 bacteria, denoted by yellow stars.
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appearance. All 37 colonies underwent further secondary selection by restreaking and growing
each putative positive colony in SD glucose media plates and subsequently growing them on
gal/raff selective media plates once again. Expression of the library proteins occurs in the
presence of galactose, but not glucose. This is due to the fact that the cDNA library protein
expression cassette is dependent upon the activation of the GAL1 promoter. After growth in
gal/raff selective media, each colony was labeled for the strength of blue color observed by its
phenotype (table 3.1). In order to discern between strong, mild or weak strength of blue color
the putative positive colonies were divided into two groups. Colonies labeled as part of the A
group were those that had strong blue color. The colonies that had a mild or a weak blue color
were labeled as part of the B group. Blue color strength of each colony was determined by
comparing them relative to each other with the strongest blue color getting a + + + + score and
the weakest a + score.
After passing the secondary selection analysis, DNA plasmids were extracted from yeast
in order to introduce them into KC8 bacteria. Since this bacterial strain has the ability to grow in
tryptophan deficient media (see Materials and Methods, chapter 2), selective growth of colonies
containing only the library plasmids was possible.

A total of 20 putative positive clones were

effectively rescued in KC8 bacteria (figure 3.1, successful electroporation clones denoted by
yellow stars).
Plasmid DNA was purified from the KC8 clones and then prepared for restriction
analysis by EcoRI/XhoI in order to determine the size of each library insert. By comparison to a
1 Kb marker, the 20 library inserts were measured and were observed to range from
approximately 1.2 to 0.8 Kb in size (figure 3.2).
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Group A Interaction strength Group B Interaction strength

3
4
5
6
10
12
13
17
19
25
28
32
36
39

+++
++++
+++
+++
+++
+++
+++
+++
+++
+++
++++
+++
+++
++++

7
8
9
11
15
16
18
21
22
23
26
27
31
37
38

++
++
+
++
++
+
++
+
+
+
+
++
++
++
++

Table 3.1
β-Galactosidase expression as observed by yeast
phenotype. Secondary selection of putative positive clones was carried
out by growth in gal/raff selective media and observed by phenotypic
expression of β-galactosidase activity as seen by varying blue color
intensities of each clone. Clone numbers are given based upon order of
appearance on selection plates. Blue color strength of each colony was
determined by comparing them relative to each other with the strongest
blue color getting a + + + + score and the weakest a + score.
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1 Kb
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Figure 3.2 Verification of cDNA library insert size.
Analysis of the 20 putative positive clones by restriction digest
with EcoRI and XhoI demonstrated that the library inserts
ranged from 1.2 to 0.8 Kb in size as observed from a 1%
agarose gel.
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Because it was possible that more than one copy of a certain clone was isolated from the
interaction screen, elimination of redundant clones was necessary prior to further analysis of
clones. Therefore, each library insert was amplified by PCR and digested with the frequent
cutter enzyme AluI. Digestion patterns were observed by loading the 20 samples on a 2%
agarose gel and comparing the digestion patterns of each (figure 3.3). Clones numbered 1
through 20 revealed that there were indeed two copies of clones 1, 2, 5, 10, and 13. Elimination
of these redundant clones yielded a net total of 15 putative positives for further analysis and
identification.
To confirm interaction specificities of the 15 putative positive clones, yeast were
retransformed with either the PhKα 1060-1237 bait or the Drosophila bicoid protein as a nonspecific bait and each putative positive clone. To test interaction specificities, yeast were grown
in SD glucose -His/-Trp/-Ura/-Leu and gal/raff -His/-Trp/-Ura/-Leu X-Gal selective media. For
true positive clones, yeast would express leucine prototrophy and β-galactosidase activity in the
presence of PhKα 1060-1237, but this would not occur in the presence of the bicoid protein.
When all the 15 putative positive clones were tested in this fashion, only 13 interacted
specifically with PhKα 1060-1237 (figure 3.4A). The clones that did not grow in selective media
were 7B and 32A. Moreover, from the interactions observed in selective media with bicoid
protein, clones 9B, 15B, 18B, 26B, and 38B did not grow and the clones that exhibited minimal
growth in the presence of bicoid protein were 28A, 39A, 11B, and 27B.

PhKα interacts with TRIP10 and TPR1
To identify each of the 13 clones that interacted with PhKα 1060-1237 each clone was
sequenced.

Each sequence was compared to the GenBank database from the National Center
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Figure 3.3 Fifteen non-redundant clones isolated. To eliminate
any redundant clones that might have been isolated from the library
screen, library inserts were amplified by PCR and further analyzed
by digestion with the frequent cutter AluI. Five clones were
eliminated as being redundant as observed from a 2% agarose gel.
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A

B

Figure 3.4 A total of 13 clones interacted exclusively with PhKα.
Thirteen clones demonstrated true interactions with PhKα 1060-1237
observed by phenotypic expression of β-galactosidase activity in yeast
(3.4A). Interaction specificities were verified by retransforming each of
the isolated clones with PhKα 1060-1237 (left). As a control, the clones
were also transformed with Drosophila bicoid protein as a non-specific
bait (right). β-Galactosidase overlay screening of putative positive
clones against the empty LexA vector (3.4B).
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for Biotechnology Information to determine the identity of the clones. From BLAST analysis,
eight overlapping clones were found to show high homology to human thyroid hormone receptor
interacting protein 10 (TRIP10). TRIP10 is also known as cdc42 interacting protein 4 (CIP4).
The nucleotide sequence was aligned to the human and mouse orthologues of TRIP10 by using
the Clustal W multiple sequence alignment tool. Sequence alignments were done by comparing
the rabbit clones of TRIP10 (CIP4) isolated from the screen to the human (accession#
NM_004240) and mouse (accession# NM_134125) orthologues. Comparison of rabbit to human
and mouse nucleotide sequence orthologues indicated that the rabbit sequence shares 86% and
82% identity respectively. The eight clones overlapped in amino acid sequence, with the largest
fragment containing residues 354 to the stop codon of the amino acid coding sequence plus an
amount of untranslated region at the 3’ end. The shortest clone was composed of residues 398 to
the stop codon of the amino acid coding sequence plus an amount of untranslated region at the 3’
end (table 3.2). Initially, when each sequence was entered to compare with the NCBI database,
the search revealed that the sequence codes for a protein that contains a complete recognizable
SH3 domain (figure 3.5).
The other five clones were identified to be highly homologous to human tetratricopeptide
repeat protein 1 (TPR1). The initial identification of the sequence via the GenBank database
revealed that the clones contain complete recognizable TPR domains (figure 3.6). The amino
acid coding sequence was determined and analyzed in the same manner as for TRIP10 (CIP4).
A comparison of the rabbit clones of TPR1 to the human (accession# NM_003314) and mouse
(accession# NM_133795) orthologues was carried out by use of the Clustal W sequence
alignment tool. Comparison of rabbit to human and mouse orthologues indicated that the rabbit
shares 90% and 87% identity, respectively. Of the five, the shortest amino acid coding sequence
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354 – 545
371 – 545
387 – 545
394 – 545
395 – 545
398 – 545

Figure 3.5 SH3 domain initially detected in TRIP10
(CIP4) clones.
Initial results from NCBI BLAST
identification revealed that the nucleotide sequences coding
for TRIP10 (CIP4) include a recognizable SH3 domain
within the coding sequence. TRIP10 (CIP4) contains a
FER-CIP4 homology (FCH) domain at the N-terminus.
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Clone # Human (545 a.a.)

Mouse (547 a.a.)

4A

394 – stop + 3’UTR(328bp)

394 – stop + 3’UTR(327bp)

10A

395 – stop + 3’UTR(280bp)

395 – stop + 3’UTR(280bp)

19A

394 – stop + 3’UTR(290bp)

394 – stop + 3’UTR(290bp)

28A

394 – stop + 3’UTR(306bp)

395 – stop + 3’UTR(282bp)

39A

371 – stop + 3’UTR(214bp)

371 – stop + 3’UTR(214bp)

9B

354 – stop + 3’UTR(96bp)

354 – stop + 3’UTR(96bp)

11B

398 – stop + 3’UTR(284bp)

398 – stop + 3’UTR(284bp)

18B

387 – stop + 3’UTR(274bp)

387 – stop + 3’UTR(274bp)

Table 3.2 Sequence Alignments with Rabbit Thyroid Hormone
Receptor Interacting Protein 10 (TRIP10) Clones.
Sequence
alignments for comparison of clones (clone# from table 3.1) from rabbit
with NCBI nucleotide sequences from human and mouse were created
online with the Clustal W multiple sequence alignment tool. Apart from
the amino acid coding sequence each clone contained matching base pairs
in the 3’ untranslated region. Stop= TGA in all clones, except 4A (TAA).
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1 – 245
1 – 242
1 – 236
1 – 233

Figure 3.6 Several TPR domains were initially
detected in the TPR1 clones. Initial results from
NCBI BLAST identification revealed that the
nucleotide sequences coding for TPR1 include several
recognizable TPR domains within the coding sequence.
TPR1 contains three TPR domains within its structure.
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Clone # Human (292 a.a.)

Mouse (292 a.a.)

15B

5’UTR(64bp) + start – 233

5’UTR(64bp) + start – 233

26B

5’UTR(64bp) + start – 245

5’UTR(64bp) + start – 244

27B

5’UTR(45bp) + start – 242

5’UTR(46bp) + start – 242

31B

5’UTR(64bp) + start – 233

5’UTR(64bp) + start – 233

38B

5’UTR(65bp) + start – 236

5’UTR(65bp) + start – 236

Table 3.3 Sequence Alignments with Rabbit Tetratricopeptide
Repeat Protein 1(TPR1) Clones. Sequence alignments for
comparison of clones (clone# from table 3.1) from rabbit with
NCBI nucleotide sequences from human and mouse were created
online with the Clustal W multiple sequence alignment tool. Apart
from the amino acid coding sequence each clone contained
matching base pairs in the 5’ untranslated region.
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was composed of an amount of untranslated region at the 5’ end plus the start of the coding
sequence to amino acid 233. The longest clone was composed of an amount of untranslated
region at the 5’ end plus the start of the coding sequence to amino acid residue 245 (table 3.3).
The fragments of TRIP10 and TPR1 identified are all independently isolated overlapping
clones, which makes them more legitimate as potential interactors. Furthermore, the fact that
more than a single clone was found to interact increases the validity of the interactions observed.

Quantification of PhKα-TRIP10 and PhKα-TPR1 Interactions
Relative interaction affinities were measured between PhKα and TRIP10 and TPR1
respectively by quantification of β-galactosidase activity at a range of 2 fg to 20ng, using a
luminescent substrate for the enzyme. The following TRIP10 and TPR1 fragments were selected
and retransformed into yeast to measure interaction affinities. To represent TRIP10 the shortest
fragment, amino acids 398 to the stop codon of the coding sequence, and the longest fragment,
amino acids 354 to the stop codon of the coding sequence, were used. To represent TPR1 the
shortest fragment, amino acids 1-233, and the longest fragment, amino acids 1-245. Each of
these TRIP10 and TPR1 fragments was screened with each of the following baits: the original
PhKα 1060-1237, PhKα 1-1059 lacking the C-terminus, a full length construct of PhKα, bicoid
protein as a nonspecific bait, and the empty LexA vector as a negative control.
When the longest fragment of TRIP10, residues 354-stop codon, (figure 3.7A) was
assayed against PhKα 1060-1237, β-galactosidase activity was measured to be 480 Modified
Miller Units (MMU) compared to 35 MMU when assayed against the nonspecific control, bicoid
protein. Although the activity differences are not statistically significant (P= 0.075) they are
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Figure 3.7 Relative interaction affinities of TRIP10 (CIP4) with various PhKα
constructs. The longest overlapping fragment of TRIP10, a.a. 354-stop (A) and the
shortest overlapping fragment a.a. 398-stop (B) were assayed with four different α
constructs: a.a. 1060-1237α (bait), a.a.1-1059 α, and full length α. The bicoid
protein and the empty LexA vector were used as negative controls. Results are
expressed as the means ± S.E.M. of three separate experiments, each carried out in
triplicate (* = p<0.05 when compared to bicoid protein)
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apparent. Interestingly, this TRIP10 fragment still shows approximately half its activity when
assayed against PhKα 1-1059 and the full length α, as compared to PhKα 1060-1237, 185 MMU
and 150 MMU, respectively. Such results are interesting given that PhKα 1-1059 does not even
contain the extreme C-terminus of α used in our two-hybrid library screen, suggesting that
residues N-terminus of a.a. 1060 likely also contribute to the interaction of PhKα and TRIP10.
The activity observed when screening these fragments with the empty LexA vector appears to be
high at 138 MMU, but such activity is not necessarily specific as this empty vector is known to
have leaky transcriptional activity. Furthermore, the fact that the β-galactosidase overlay
screening results for this construct expressed only minimal auxotrophic growth and activity
compared to the positive control p53 with SV40 T antigen (figure 3.4B) suggests that these
activity levels are not valid. LexA is generally known to express leaky transcription as an empty
vector.
Activity when the shortest overlapping fragment of TRIP10, amino acids 398-stop codon,
is assayed the β-galactosidase activity is approximately two-fold higher, 605 MMU, with PhKα
1060-1237 than the observed with the longest fragment of TRIP10 (figure 3.7B). Additionally,
PhKα 1-1059 and the full length α show the same patterns of activity as with the longest
fragment of TRIP10. The β-galactosidase activity for PhKα 1-1059 is 230 MMU and full length
α 200 MMU, compared to the bicoid protein. The activity of PhKα 1-1059 is significantly
different (P=0.041), but full length α is not (P=0.148). Still, the activity observed with the bicoid
protein was only 22 MMU. When compared to the bicoid protein, PhKα 1060-1237 is
significantly higher (P=0.042) in activity. Although the activity with the empty LexA vector is
193 MMU, such results are not completely viable once again, from the β-galactosidase overlay
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assays it can be observed that yeast containing this plasmid do not really express the activity
(figure 3.4B).
The longest overlapping fragment of TPR1, amino acids 1-245, assayed against PhKα
1060-1237, expressed β-galactosidase activity measured at 170 MMU (figure 3.8A) compared to
30 MMU when assayed against the bicoid protein. Moreover, the activities observed with PhKα
1-1059 and the full length α were 181 MMU and 117 MMU respectively. Thus, the activity
observed with PhKα 1-1059 is higher than with PhKα 1060-1237.
Interestingly, the shortest overlapping fragment of TPR1, amino acids 1-233, does exhibit
more predictable activity patterns with respect to the different α subunit constructs (figure 3.8B).
About a two-fold higher activity is observed with the shortest TPR1 fragment than with the
longest. With PhKα 1060-1237, the shortest fragment exhibits 325 MMU of β-galactosidase
activity. When assayed against the bicoid protein, the activity measured was 25 MMU. The
difference between these two activities measured is significant (P=0.035). PhKα 1-1059 and the
full length α display activity with almost the same intensities, 110 MMU and 109 MMU
respectively. When compared to the bicoid protein, the activity observed with PhKα 1-1059 is
significantly different, (P=0.027) but not with the full length α construct (P=0.084). The activity
measured against the empty LexA vector was of 137 MMU, although the same assumption holds
for all cases, that there may be some transcriptional read-through and the fact that the
luminescent β-galactosidase substrate used is highly sensitive. Evidence for this hypothesis can
be observed from the β-galactosidase overlay screening results (figure 3.4B).
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Figure 3.8 Relative interaction affinities of TPR1 with various PhKα constructs.
The longest overlapping fragment of TPR1, a.a. start-245 (A) and the shortest
overlapping fragment a.a. start-233 (B) were assayed with four different α constructs:
a.a. 1060-1237α (bait), a.a. 1-1059 α, and full length α. The bicoid protein and the
empty LexA vector were used as controls negative. Results are expressed as the means
± S.E.M. of three separate experiments, each carried out in triplicate (* = p<0.05 when
compared to bicoid protein)
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Each construct, both TRIP10 and TPR1, demonstrated low activity when assayed against
the Drosophila bicoid protein. Additionally, the fact that interactions also occur between
TRIP10 and TPR1 and the full length α subunit implies that these interactions are valid within
the context of the holoenzyme. The observation that β-galactosidase activity is significantly
reduced when these constructs are assayed against the full length α however, is likely due to the
fact that the full length α subunit construct is farnesylated, thus it only has a 50/50 chance to
travel to the yeast nucleus to interact with the prey.
Overall, when the activity levels of PhKα 1060-1237 and TRIP10 are compared to those
between PhKα 1060-1237 and TPR1, TRIP10 levels are approximately 2-3 fold higher than
TPR1, 500-600 MMU versus 200-300 MMU. These results, while not a complete measure of
binding affinity, do suggest that PhKα 1060-1237 interacts more strongly with TRIP10 than
TPR1. This is also suggested by the fact that the full length α construct also demonstrates
activity levels for TRIP10 that are also approximately 2-fold higher than with TPR1.

CHAPTER IV
DISCUSSION

By using a yeast two-hybrid screen to identify novel binding partners for the α subunit of
PhK, I have identified two new skeletal muscle proteins that interact with the C-terminus,
residues 1060-1237, of PhKα. These proteins are TRIP10 also known as CIP4, and TPR1.
TRIP10 (CIP4) Background
TRIP10 was first described as a protein that associates with thyroid hormone receptors
(TR), transcription factors that depend on hormones to regulate specific genes. TRIP10
enhances hormone activation with relation to gene regulation by its hormone dependent
interaction with TRβ (Lee et al., 1995) (Tsuji and Tsuji, 2000). It has been described to be
homologous to the Formin-binding protein FNBP1 and to forming-binding protein 17 having in
common a FCH domain and a C-terminal SH3 domain (Katoh and Katoh, 2004) (Morin et al.,
2003). CIP4 (TRIP10) is a 545 amino acid protein with a mass of 63 kDa that is involved in
regulation of the actin cytoskeleton by serving as a scaffold protein for localization and
organization of explicit intracellular molecules (Aspenström, 1997) (Wang et al., 2002).
Additionally, CIP4 has been shown to be a downstream target of Cdc42 by enhancing its GTPase
activity (Aspenström, 1997).
The CIP4 gene is approximately 14 Kb in size containing 15 exons. Specifically, the
CIP4 gene for humans is located at chromosome 19p13.3, and the gene codes for two isoforms of
the protein (Wang et al., 2002). The other isoform of CIP4 is CIP4/2, which contains an FCH
domain, two coil-coiled domains and an SH3 domain as well. CIP4/2 functions as an adapter
protein, and it is thought to function in recruitment of proteins to the plasma membrane in
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response to insulin for the translocation of Glut4 to the cell surface (Chang et al., 2002). Several
known protein motifs exist in the primary structure of CIP4. The first 300 amino acids of CIP4
are homologous to the non-catalytic portion of FER, a non-receptor tyrosine kinase, and also to
the Fujinami Sarcoma virus Fes/Fps family of proto-oncogene proteins. Amino acids 1-56, at the
N-terminus of CIP4, code for a new motif called FER-CIP4 homology (FCH) domain, which has
also been described in other proteins including FER, CIP4, and RhoGAP protein p115 among
others. FCH containing proteins are suspected to be involved in the organization of Rho proteins
and the actin cytoskeleton (Aspenström, 1997). The FCH domain in CIP4 allows for binding to
microtubules (Tian et al., 2000). Additionally, the C-terminus of CIP4 contains a classical SH3
domain, also known to be involved in protein interactions (Aspenström, 1997).
CIP4 has been shown to be expressed in skeletal muscle, heart and placenta. More
specifically, localization in Swiss 3T3 fibroblasts revealed that Cdc42 is an important component
for the formation of filopodia at the cell periphery that are composed of tightly packed actin
filaments with their fast growing ends directed towards the periphery. Although CIP4 does not
contain any regions homologous to proteins that bind directly to actin, it is involved in the
recruitment of actin monomers for an increment of unpolymerized actin, thus stimulating
filopodia formation at the cell periphery (Aspenström, 1997). It has been described that overexpression of CIP4 in fibroblasts causes filamentous actin bundles to disappear (Richnau and
Aspenström, 2001). Moreover, based on protein structure and gene coding characteristics, it is
very likely that CIP4 is also involved in specific signaling processes within the cell (Wang et al.,
2002).
A known binding partner of CIP4 is the Wiskott-Aldrich syndrome protein (WASP), a
protein that is composed of 502 amino acids and contains proline rich domains within its
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structure. WASP is involved in actin cytoskeleton organization and interacts with CIP4 by direct
binding to the SH3 domain of CIP4 through its proline rich region (Tian et al., 2000). Another
binding partner of CIP4 is RICH-1, a newly described protein that possesses a RhoGAP domain.
RICH-1 is involved in serving as a specific GAP for Rac and Cdc42. Knowledge of new Rho
GTPases enhances the understanding of how proteins act in mobilization of the microfilament
system (Richnau and Aspenström, 2001). CIP4 has also been associated with Huntington’s
disease (HD) by its accumulation in HD affected brain tissue. It is thought that increased CIP4
expression may be associated with progression of the disease (Holbert et al., 2003).

TPR1 Background
TPR1, a proposed adaptor protein, is composed of 292 amino acids and is highly
hydrophilic. The human gene for TPR1 has been localized to chromosome 5, specifically to
5q32-33.2, which is the loci associated with various diseases such as limb girdle muscular
dystrophy, Treacher Collins Syndrome, autosomal deafness, and diastrophic dysplasia
(Warrington et al., 1991). In its primary sequence, TPR1 contains many glutamic acid residues
more noticeably at its N-terminus. It has been described to possess homology with class III TPR
containing proteins that have a wide array of roles ranging from stress response, interferon
response and association with mitochondrial chaperones. Tetratricopeptide repeat (TPR)
components are 34-amino-acid degenerate repeating motifs that were first described in fungal
proteins involved in cell division. TPR1 contains three of these domains within its structure
(Murthy et al., 1996). Another distinctive domain within TPR1 is a small portion of five amino
acids in its central groove that is called the “two-carboxylate clamp” a domain that serves as a
binding site for a protein ligand. TPR1 binds preferentially to hydrophobic residues on its target
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protein, moreover, it was determined that it recognizes the EEVD motif present at the C-terminal
of proteins from the Hsp70 and Hsp90 groups (Brinker et al., 2002).
TPR motifs were named as such in 1990 because of the 34 amino acids that form the
structure (D’Andrea and Regan, 2003). The motifs can form α helix arrays that are 20 to 30
residues enhanced by a proline-induced four-residue turn at the C-terminus of each repeat. TPR
motifs have been identified in several proteins involved in a wide variety of pathways thus the
specific function of these domains is unknown but suggested as important stability components
for the molecule they reside in. Likely, TPR domains are involved in mediating protein-protein
interactions and are similarly present in both prokaryotes and eukaryotes (Murthy et al., 1996)
(D’Andrea and Regan, 2003).
A mutation in TPR1 has been associated with a decrease in co-clustering of rapsyn with
the acetylcholine receptor (AChR), leading to a deficiency of the latter and contribution to
Myasthenic Syndrome. Rapsyn is responsible for recruiting AChR to the postsynaptic
membrane at the motor end plate (Ohno et al., 2002). Another TPR containing protein involved
in disease is TPR Down (TPRD), which is coded at the same chromosomal region as for Down
Syndrome. Increased TPRD levels were found in fetuses with Down Syndrome. Although the
binding partner for this protein is yet to be discovered, such information could provide more
insight for the etiology of Down Syndrome (D’Andrea and Regan, 2003). In Fanconi Anemia
(FA), a syndrome that causes developmental abnormalities, pancytopenia and cancer
susceptibility, it has been described that an FA protein, FANCG, contains about 4 TPR motifs
within its structure. Mutations in FANCG are implicated in the instability of the interaction with
FANCA, another FA protein, thus causing an unstable FA protein complex leading to pathology.

58
It is thought that the mutations possibly occur at the protein-protein interaction TPR motifs
(Blom et al., 2004).
A known binding partner of TPR1 is the ATP dependent 70 kDa heat-shock cognate
protein (hsc70), which functions as a molecular chaperone. The interaction between the two
occurs by means of hsc70 C-terminus (Wu et al., 2001). Yet another role of TPR1 is to provide
with the specificity of the interaction between mSTI1 and Hsp70, by serving as an adaptor
through its hydrophobic residues Ala49 and Lys50 present in the second TPR motif (Odunuga et
al., 2003). Another interaction involving TPR domains occurs with p67phox, which forms part of
the NADPH oxidase enzyme complex, a protein that contains a TPR domain that has a β-hairpin
insertion allowing it to interact with the GTPase Rac (Brinker et al., 2002). TPR1 is also
involved in G-protein signaling. It functions as an adaptor for the interaction between specific
Gα proteins, Gα16 and Ras. The interaction may be via a TPR1 stabilization of Ras, which
causes an increase of the active form of Ras. Overexpression of TPR1 has been shown to
stimulate both the accumulation of Ras and phosphorylation of ERK1/2 (p44/p42) (Marty et al.,
2003).

Proposed Mechanism of PhKα Interactions with TRIP10 and TPR1
When PhKα 1060-1237 was used to screen a rabbit skeletal muscle cDNA library, two
novel interactions were identified. These two proteins were identified as TRIP10 (CIP4) and
TPR1. Furthermore, 8 and 5 overlapping fragments were isolated for each, thus confirming the
genuineness of each interaction.
PhKα 1060-1237 may recognize TRIP10 (CIP4) at its proline rich domain. As
previously mentioned, the C-terminus of TRIP10 (CIP4) possesses an SH3 domain implicating a
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possible means of association with PhKα. It is possible that PhKα 1060-1237 recognizes the SH3
domain in TRIP10 (CIP4). The SH3 domain in TRIP10 (CIP4) is located at amino acid residues
484 to 545, and amino acid 545 is the C-terminal residue. Residues 398-483 were not found to
contain any other recognizable domain. The recognition sequence for SH3 domains is a proline
rich sequence, but in this case it is not one that falls into either of the classical SH3 class I or
class II domains. Instead, the SH3 domain of TRIP10 (CIP4) contains the majority of the proline
rich sequences (PXXP) in more than one frame.
The cognate binding domain on PhKα 1060-1237 that likely recognizes TRIP10 (CIP4) is
a WW domain found at residue 1107 and residue 1129, within the PhKα sequence. WW
domains are small modules made up of 40 amino acid residues and named as such because two
distinctive tryptophan (W) residues are spaced 20 to 22 amino acids apart. The WW domain
found in PhKα is exactly 22 amino acids apart. These domains recognize proteins that contain
proline rich domains, and are known to mediate protein-protein interactions (Macias et al., 2002)
(Sudol et al., 1995). The WW domain found within PhKα falls into group I of these domains.
Group I WW domains bind protein sequences with a minimal consensus of PPxY (Macias et al.,
2002). TRIP10 (CIP4) contains two PPxS sequences, thus the S might be considered a
functionally conserved substitution.
In the muscle sarcomere, PhK has been found to interact with nebulin, a component of
the thin filament. Nebulin binds actin and is believed to define the registry of the actin filaments
on the sarcomere. The fact that TRIP10 (CIP4) associates with actin filaments as well further
suggests that the interaction between PhKα and TRIP10(CIP4) is not only real, but also
physiologically relevant. It has been suggested that PhK’s association with the thin filaments of
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muscle may provide a means of activation of the holoenzyme through mechanical contraction of
the sarcomere (Ayers, Ph.D. dissertation, 1999).
TPR1, as mentioned above, is an adaptor protein and as such interacts with a wide array of
proteins in different signaling pathways. According to Murthy et al. (1996), TPR proteins appear
to have the tendency in interacting non-selectively with other proteins, but they argue that if such
is the case, then these TPR-containing proteins would be isolated frequently from two-hybrid
screens. Therefore, it is possible that the association of PhKα and TPR1 may be a false positive.
Moreover, it has been found that interactions involving TPR proteins are indeed specific (Murthy
et al., 1996). Why TPR1 may be interacting with PhKα 1060-1237 is still somewhat unclear.
Although how the interaction is occurring is more predictable. Since each TPR1 fragment
isolated coded for the N-terminus of the protein, the smallest fragment being amino acids 1-233,
it can be implied that this region of the protein interacts with PhKα. Clearly the overlapping
fragments interacting do contain the 3 TPR motifs, and are interacting with the C-terminus of
PhKα. It is important to note that PhKα 1060-1237 does not contain an EEVF motif within the
sequence, which is known to be recognized by TPR1. In order to discern the purpose of the
interaction between PhKα 1060-1237 and TPR1 it would be useful to screen the same type of
cDNA library used in this project against TPR1. Results from this screen could provide
information on binding partners on the other side of TPR1, opposite the N-terminus where it
interacts with PhKα 1060-1237.

Conclusion
The α subunit is the largest of the components of PhK and together with the β subunit
represents 81% of the total holoenzyme mass. The amount of PhK expressed in skeletal muscle
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exceeds what is necessary for glycogenolysis regulation, therefore it is possible that the
holoenzyme has other roles in the cell (Pallen, 2003).
In this study we have found by two-hybrid screening that the α subunit of PhK interacts
with the novel proteins TRIP10 (CIP4) and TPR1. The association of TRIP10 (CIP4) with the
actin filaments implies a novel potential role for PhK in muscle sarcomere assembly and
architecture. Future directions will focus on the co-localization of PhK with TRIP10 (CIP4) in
muscle cells to observe the relationship between the two in their natural environment.
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